Fri, February 16, 2024

by: WOPRAI

Srini Pajjuri Maintained (AMAT) at Buy with Increased Target to $225 on, Feb 16th, 2024

by: WOPRAI

Craig Ellis Reiterated (AMAT) at Strong Buy with Increased Target to $250 on, Feb 16th, 2024

by: WOPRAI

Atif Malik Maintained (AMAT) at Strong Buy with Increased Target to $211 on, Feb 16th, 2024

by: WOPRAI

Toshiya Hari Maintained (AMAT) at Strong Buy with Increased Target to $220 on, Feb 16th, 2024

by: WOPRAI

Timothy Arcuri Maintained (AMAT) at Hold with Increased Target to $185 on, Feb 16th, 2024

by: WOPRAI

Vijay Rakesh Maintained (AMAT) at Strong Buy with Increased Target to $225 on, Feb 16th, 2024

by: WOPRAI

Vivek Arya Maintained (AMAT) at Strong Buy with Increased Target to $222 on, Feb 16th, 2024

by: WOPRAI

Joseph Moore Maintained (AMAT) at Hold with Increased Target to $206 on, Feb 16th, 2024

by: WOPRAI

Salveen Richter Downgraded (ALNY) to Hold and Decreased Target to $173 on, Feb 16th, 2024

by: WOPRAI

Keay Nakae Maintained (ALNY) at Strong Buy with Decreased Target to $225 on, Feb 16th, 2024

by: WOPRAI

David Lebovitz Maintained (ALNY) at Strong Buy with Decreased Target to $227 on, Feb 16th, 2024

by: WOPRAI

Tiago Fauth Maintained (ALNY) at Hold with Decreased Target to $161 on, Feb 16th, 2024

by: WOPRAI

Luca Issi Reiterated (ALNY) at Buy and Held Target at $235 on, Feb 16th, 2024

by: WOPRAI

Graig Suvannavejh Maintained (AXSM) at Strong Buy with Increased Target to $112 on, Feb 16th, 2024

by: WOPRAI

Salveen Richter Maintained (ADPT) at Hold with Decreased Target to $5 on, Feb 16th, 2024

by: WOPRAI

Conor McNamara Maintained (BIO) at Buy with Decreased Target to $480 on, Feb 16th, 2024

by: WOPRAI

Dan Leonard Maintained (BIO) at Strong Buy with Increased Target to $420 on, Feb 16th, 2024

by: WOPRAI

Jon Tower Maintained (BJRI) at Hold with Increased Target to $37 on, Feb 16th, 2024

by: WOPRAI

Nick Setyan Reiterated (BJRI) at Buy and Held Target at $40 on, Feb 16th, 2024

by: WOPRAI

Joshua Long Reiterated (BJRI) at Hold and Held Target at $35 on, Feb 16th, 2024

by: WOPRAI

Ittai Kidron Maintained (BLZE) at Buy with Increased Target to $11 on, Feb 16th, 2024

by: WOPRAI

Simon Leopold Maintained (BLZE) at Buy with Increased Target to $14 on, Feb 16th, 2024

by: WOPRAI

Gregory Renza Maintained (AGIO) at Buy with Decreased Target to $42 on, Feb 16th, 2024

by: WOPRAI

David Amsellem Maintained (ALKS) at Buy with Increased Target to $39 on, Feb 16th, 2024

by: WOPRAI

Aleksey Yefremov Maintained (ALB) at Buy with Decreased Target to $178 on, Feb 16th, 2024

by: WOPRAI

Colin Rusch Maintained (ALB) at Buy with Decreased Target to $188 on, Feb 16th, 2024

by: WOPRAI

Arun Viswanathan Maintained (ALB) at Buy with Decreased Target to $138 on, Feb 16th, 2024

by: WOPRAI

Michael Sison Maintained (ALB) at Buy with Decreased Target to $135 on, Feb 16th, 2024

by: WOPRAI

Charles Shi Maintained (AMAT) at Strong Buy with Increased Target to $240 on, Feb 16th, 2024

by: WOPRAI

Mehdi Hosseini Maintained (AMAT) at Hold with Increased Target to $160 on, Feb 16th, 2024

by: WOPRAI

Brian Chin Maintained (AMAT) at Strong Buy with Increased Target to $230 on, Feb 16th, 2024

by: WOPRAI

Andrew Kaplowitz Maintained (VNT) at Strong Buy with Increased Target to $45 on, Feb 16th, 2024

by: WOPRAI

Robert Jamieson Maintained (VNT) at Strong Buy with Increased Target to $46 on, Feb 16th, 2024

by: WOPRAI

Jade Rahmani Maintained (BXMT) at Hold with Decreased Target to $21 on, Feb 16th, 2024

by: WOPRAI

David Lebowitz Maintained (BPMC) at Strong Sell with Increased Target to $65 on, Feb 16th, 2024

by: WOPRAI

Reni Benjamin Reiterated (BPMC) at Buy and Held Target at $114 on, Feb 16th, 2024

by: WOPRAI

Chris O"Cull Maintained (WING) at Strong Buy with Increased Target to $330 on, Feb 16th, 2024

by: WOPRAI

Mark Astrachan Maintained (WMT) at Hold with Increased Target to $58 on, Feb 16th, 2024

by: WOPRAI

Bobby Griffin Upgraded (W) to Strong Buy and Held Target at $65 on, Feb 16th, 2024

by: WOPRAI

Seth Basham Reiterated (W) at Buy and Held Target at $70 on, Feb 16th, 2024

by: WOPRAI

Jade Rahmani Maintained (WD) at Hold with Decreased Target to $105 on, Feb 16th, 2024

by: WOPRAI

Henry Coffey Reiterated (WD) at Buy and Held Target at $130 on, Feb 16th, 2024

by: WOPRAI

Sarang Vora Maintained (WEST) at Buy with Increased Target to $13 on, Feb 16th, 2024

by: WOPRAI

Nick Setyan Maintained (WEN) at Hold with Decreased Target to $19 on, Feb 16th, 2024

by: WOPRAI

Andrew Strelzik Maintained (WEN) at Hold with Decreased Target to $20 on, Feb 16th, 2024

by: WOPRAI

Brian Yarbrough Downgraded (BKNG) to Hold on, Feb 16th, 2024

by: WOPRAI

Joseph Stringer Reiterated (STOK) at Strong Buy and Held Target at $14 on, Feb 16th, 2024

by: WOPRAI

Rohit Seth Maintained (SUM) at Strong Buy with Increased Target to $46 on, Feb 16th, 2024

Gregory Renza Maintained (AGIO) at Buy with Decreased Target to $42 on, Feb 16th, 2024

Gregory Renza of RBC Capital, Maintained "Agios Pharmaceuticals, Inc." (AGIO) at Buy with Decreased Target from $43 to $42 on, Feb 16th, 2024.

Gregory has made no other calls on AGIO in the last 4 months.



There are 2 other peers that have a rating on AGIO. Out of the 2 peers that are also analyzing AGIO, all agree with Gregory's Rating of Hold. Following are those relevant analyst calls for the last 4 months

  • Tessa Romero of "JP Morgan" Maintained at Hold with Increased Target to $31 on, Tuesday, January 23rd, 2024
  • Salveen Richter of "Goldman Sachs" Maintained at Hold with Decreased Target to $28 on, Friday, November 3rd, 2023